RYAHF (RYAH Group) Revenue: $0.13 Mil (TTM As of Sep. 2022)


What is RYAH Group Revenue?

RYAH Group RYAHF Revenue is $0.13 Mil as of Sep. 2022.

RYAH Group's revenue for the three months ended in Sep. 2022 was $0.01 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2022 was $0.13 Mil. RYAH Group's Revenue per Share for the three months ended in Sep. 2022 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


RYAH Group  (OTCPK:RYAHF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


RYAH Group Revenue Related Terms


RYAH Group Revenue Historical Data

* Premium members only.

The historical data trend for RYAH Group's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RYAH Group Revenue Chart

RYAH Group Annual Data
Trend Dec20 Dec21
Revenue
0.04 0.17

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Revenue Get a 7-Day Free Trial 0.01 0.07 0.00 0.05 0.01

RYAHF vs CERN, VEEV, CHNG: Revenue Comparison

For the Health Information Services subindustry, RYAH Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RYAH Group Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RYAH Group's Revenue distribution charts can be found below:

* The bar in red indicates where RYAH Group's Revenue falls into.



RYAH Group Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $0.13 Mil mean?
RYAH Group (RYAHF) has a Revenue of $0.13 Mil as of Sep. 2022. Revenue is the total amount a company generates as sales through its operations. View historical data on RYAH Group and its competitors.
Is RYAH Group's Revenue too high?
RYAH Group's current Revenue is $0.13 Mil.
How does RYAH Group's Revenue compare to CERN and VEEV?
RYAH Group's Revenue of $0.13 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on RYAH Group and its competitors. RYAH Group's current Revenue is $0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current Revenue of $0.13 Mil. The current Revenue is $0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For RYAH Group (RYAHF), the current Revenue is $0.13 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RYAH Group Business Description

Address 68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.